Pharmacogenetic testing versus standard prescribing of psychotropics for the treatment of severe mood disorders: A randomized controlled trial protocol

Authors

Institutions

Publication Details

Journal
Pharmacogenetics and Genomics
Published
2025-11-19
DOI
https://doi.org/10.1097/fpc.0000000000000585
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacogenetic testing versus standard prescribing of psychotropics for the treatment of severe mood disorders: A randomized controlled trial protocol

Angela Komiti, Malcolm Hopwood, Melanie Hurley, Chad Bousman
Pharmacogenetics and Genomics
Tryptophan and brain disorders
article

Pharmacogenetic testing versus standard prescribing of psychotropics for the treatment of severe mood disorders: A randomized controlled trial protocol

Angela Komiti, Malcolm Hopwood, Melanie Hurley, Chad Bousman
article en

Abstract

No abstract available for this paper.
Pharmacogenetics and GenomicsVol. 36(2)
The University of Melbourne (AU), University of Calgary (CA), Melbourne Clinic (AU)
Openalex Percentile: Top 58%
Tryptophan and brain disorders
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.